Statement of amendment to the annual flu letter for 2023 to 2024 – 3 July 2023
Updated 3 July 2023
© Crown copyright 2023
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan/statement-of-amendment-to-the-annual-flu-letter-for-2023-to-2024-3-july-2023
1. The annual flu vaccination programme letter (“annual flu letter”) of 25 May 2023 is hereby amended to reflect the addition to the programme of secondary school-aged children in Years 7, 8, 9, 10 and 11 (including home-schooled and other children not in mainstream education). Providers should ensure they commence vaccinations as early as possible after the flu vaccine becomes available and complete by 15 December 2023 in line with the other school aged cohorts already announced.
2. As set out in the annual flu letter, the live attenuated influenza vaccine (LAIV) should be offered to eligible children aged from 2 years to less than 18 years of age unless contraindicated or where parents object to LAIV on the grounds of its porcine gelatine content. Where LAIV is unsuitable, children should be offered the injectable cell-based Quadrivalent Influenza Vaccine (QIVc). Children’s vaccines will be available to order through ImmForm.